|
🐜
|
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial
119 auth.
M. Datoo,
A. Dicko,
H. Tinto,
Jean-Bosco Ouédraogo,
M. Hamaluba,
A. Olotu,
Emma Beaumont,
F. R. Lopez,
H. M. Natama,
Sophie Weston,
Mwajuma Chemba,
Y. Compaoré,
Djibrilla Issiaka,
Diallo Salou,
A. Somé,
...
Sharon Omenda,
A. Lawrie,
P. Bejon,
Harish Rao,
D. Chandramohan,
Rachel Roberts,
Sandesh M. Bharati,
L. Stockdale,
Sunil Gairola,
Brian Greenwood,
K. Ewer,
J. Bradley,
P. Kulkarni,
U. Shaligram,
ADRIAN V. S. Hill,
A. Mahamar,
K. Sanogo,
Youssoufa Sidibé,
Kalifa Diarra,
Mamoudou Samassekou,
Oumar Attaher,
Amadou Tapily,
M. Diallo,
O. Dicko,
Mahamadou Kaya,
S. O. Maguiraga,
Yaya Sankaré,
Hama Yalcouye,
Soumaïla Diarra,
S. M. Niambele,
Ismaila Thera,
I. Sagara,
Mala Sylla,
A. Dolo,
Nsajigwa Misidai,
Sylvester Simando,
H. Msami,
O. Juma,
Nicolaus Gutapaka,
R. Paul,
S. Mswata,
I. Sasamalo,
Kasmir Johaness,
Mwantumu Sultan,
Annastazia Alexander,
Isaac Kimaro,
Kauye Lwanga,
Mwajuma Mtungwe,
Kassim Khamis,
Lighton Rugarabam,
W. Kalinga,
Mohammed Mohammed,
Janeth Kamange,
Jubilate Msangi,
Batuli Mwaijande,
I. Mtaka,
Matilda Mhapa,
Tarsis Mlaganile,
Thabit Mbaga,
R. Yerbanga,
Wendkouni Samtouma,
Abdoul-Aziz Sienou,
Zachari Kabré,
W. Ouedraogo,
G. A. B. Yarbanga,
I. Zongo,
Hamade Savadogo,
J. Sanon,
Judicael Compaore,
Idrissa Kéré,
Ferdinand Lionel Yoni,
Tewende Martine Sanre,
Seydou Bienvenu Ouattara,
S. Provstgaard-Morys,
D. Woods,
Robert W Snow,
Nyaguara O. Amek,
Caroline J Ngetsa,
L. Ochola-Oyier,
J. Musyoki,
M. Munene,
Noni Mumba,
Uche J. Adetifa,
Charles Muiruri,
Jimmy Shangala Mwawaka,
M. H. Mwaganyuma,
Martha Njeri Ndichu,
J. Weya,
Kelvin Njogu,
Jane Grant,
J. Webster,
Anand Lakhkar,
N. F. A. Ido,
Ousmane Traore,
M. Tahita,
M. D. A. Bonko,
T. Rouamba,
D. F. Ouédraogo,
Rachidatou Soma,
Aida Millogo,
Edouard Ouédraogo,
Faizatou Sorgho,
Fabé Konaté,
I. Valéa
|
6 |
2024 |
6
🐜
|
|
🐜
|
Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial.
43 auth.
S. Silk,
W. Kalinga,
J. Salkeld,
I. Mtaka,
Saumu Ahmed,
F. Milando,
A. Diouf,
C. K. Bundi,
N. Balige,
O. Hassan,
C. Mkindi,
S. Rwezaula,
T. Athumani,
Sarah Mswata,
N. S. Lilolime,
...
B. Simon,
H. Msami,
M. Mohamed,
D. M. David,
L. Mohammed,
G. Nyaulingo,
B. Mwalimu,
O. Juma,
T. G. Mwamlima,
I. Sasamalo,
R. P. Mkumbange,
J. J. Kamage,
J. Barrett,
L. King,
M. Hou,
D. Pulido,
C. Carnrot,
A. Lawrie,
R. Cowan,
F. L. Nugent,
Rachel Roberts,
J. Cho,
C. Long,
C. M. Nielsen,
K. Miura,
S. Draper,
A. Olotu,
A. Minassian
|
3 |
2024 |
3
🐜
|
|
🐜
|
Safety and Tolerability of an Antimalarial Herbal Remedy in Healthy Volunteers: An Open-Label, Single-Arm, Dose-Escalation Study on Maytenus senegalensis in Tanzania
26 auth.
Kamaka Kassimu,
F. Milando,
J. Omolo,
A. Mdemu,
G. Nyaulingo,
Hussein Mbarak,
Latipha Mohamed,
Ramla Rashid,
Saumu Ahmed,
Mohammed Rashid,
H. Msami,
David Damiano,
B. Simon,
Thabit Mbaga,
Fatuma Issa,
...
Omar N. Lweno,
N. Balige,
O. Hassan,
B. Mwalimu,
Ali Hamad,
A. Olotu,
A. Mårtensson,
F. Machumi,
Said Jongo,
B. Ngasala,
S. Abdulla
|
2 |
2022 |
2
🐜
|
|
🐜
|
First Phase 1b, single-center, age de-escalation trial of the P. falciparum blood-stage malaria vaccine candidate RH5.1/Matrix-Mâ¢: a delayed boost regimen induces high levels of functional antibodies in 5-17 month old Tanzanian infants
43 auth.
S. Silk,
W. Kalinga,
J. Salkeld,
I. Mtaka,
S. Ahmed,
F. Milando,
A. Diouf,
C. K. Bundi,
N. Balige,
O. Hassan,
C. Mkindi,
S. Rwezaula,
T. Athumani,
S. Mswata,
N. S. Lilolime,
...
B. Simon,
H. Msami,
M. Mohamed,
D. M. David,
L. Mohammed,
G. Nyaulingo,
B. Mwalimu,
O. Juma,
T. G. Mwamlima,
I. Sasamalo,
R. P. Mkumbange,
J. J. Kamage,
J. Barrett,
L. King,
M. Hou,
D. Pulido,
C. Carnrot,
A. M. Lawrie,
R. Cowan,
F. L. Nugent,
R. Roberts,
J.-S. Cho,
C. Long,
C. M. Nielsen,
K. Miura,
S. Draper,
A. I. Olotu,
A. Minassian
|
0 |
2024 |
0
🐜
|
